Opposite regulation of intestinal and intrahepatic CD8<sup>+</sup> T cells controls alcohol-associated liver disease progression.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40199574.
- Also identified by DOI 10.1136/gutjnl-2024-334412 and PMC identifier 12234235.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gut-liver crosstalk plays an important role in alcohol-associated liver disease (ALD) pathogenesis; but underlying mechanisms remain obscure. We examined the regulation of intestinal and intrahepatic CD8<sup>+</sup> T lymphocytes and their contribution to ALD. ALD patients were recruited for evaluation of intestinal and liver T cells. Single-cell RNA sequencing (scRNA seq) was performed to analyse intrahepatic and peripheral T cells in ALD. Wildtype, CD8-specific <i>Bcl2</i> transgenic (<i>Cd8</i> <sup>Bcl-2</sup>), and <i>Cd8</i> <sup>-/-</sup> mice were subjected to chronic-plus-binge ethanol feeding. In ALD patients, duodenal CD8<sup>+</sup> T cells were selectively reduced and negatively correlated with liver injury and bacterial translocation markers, while intrahepatic CD8<sup>+</sup> T cells were markedly increased. ScRNA seq analysis of ALD patient livers revealed several populations of CD8<sup>+</sup> T cells expressing activation and survival genes (eg, <i>Bcl2</i>). Transcriptomics and functional studies revealed a key role of prosurvival BCL2 in this opposite regulation of CD8<sup>+</sup> T cells. Mechanistically, chronic-plus-binge ethanol feeding reduced CD8<sup>+</sup> T cells specifically in the duodenum where ethanol levels are high. Inducing BCL2 in CD8<sup>+</sup> T cells reversed ethanol-induced loss of duodenal CD8<sup>+</sup> T cells, improved gut barrier function and ameliorated ALD, while CD8 deficiency was linked to enhanced neutrophil and macrophage infiltration in the liver, exacerbating ALD in mice. ALD is associated with loss of duodenal CD8<sup>+</sup> T cells but elevation of intrahepatic CD8<sup>+</sup> T cells, which aggravates and ameliorates ALD, respectively. Restoration of survival and functions of intestinal and intrahepatic CD8<sup>+</sup> T cells may represent a novel therapeutic strategy for ALD patients.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Liver Diseases, Alcoholic
- Liver
- Duodenum